Pipeline

Paragraphes
Colonne 1

Currently, 8 treatments are in advanced stages of development which 7 for emergency situations.

A medical emergency requires quick action to ward off a risk of imminent death and long-term sequelae, or to manage a situation of stress or crisis. People facing an emergency, especially if they themselves are the victim, need an immediate therapeutic solution.

Colonne 2

The physical and/or psychological state of a person having an epileptic seizure, experiencing anaphylactic shock or suffering an overdose does not permit a sure medical gesture, ever more so if it involves syringes and needles.

With ZENEO® : the prefilled, needleless, single-use device is specifically conceived for self-administration, even in the most stressing situations..

Zeneo® Sumatriptan

Visuel du produit
Description du produit

ZENEO® Sumatriptan : Treatment for migraines and cluster headaches

Sumatriptan injection is the standard of care for migraines and cluster headaches.

Zeneo® Adrenaline

Visuel du produit
Description du produit

ZENEO® Adrénaline : Treatment for anaphylactic shock

Anaphylactic shock is an extreme allergic reaction against an antigen to which a person has become hypersensitive.

Zeneo® Hydrocortisone

Visuel du produit
Description du produit

ZENEO® Hydrocortisone : Treatment for acute adrenal crisis

Acute adrenal crisis is recognizable by its typical symptoms of diarrhea, vomiting and nausea.

Zeneo® Midazolam

Visuel du produit
Description du produit

ZENEO® Midazolam : Treatment in epileptic seizure

Epilepsy is a neurological disorder that knows no age limit. According to the WHO, it affects approximately 50 million people worldwide.

Zeneo® Naloxone

Visuel du produit
Description du produit

ZENEO® Naloxone : Treatment in opioid overdose

According to United Nations data, opiate use is present in 2% of the American population and is growing by 10% each year.

Zeneo® Apomorphine

Visuel du produit
Description du produit

ZENEO® Apomorphine : Salvage treatment for temporary paralysis in Parkinson's disease

Parkinson's disease affects 700,000 people in Europe, 1.2 million in the United States, and 6.3 million worldwide.

Zeneo® Methotrexate

Visuel du produit
Description du produit

ZENEO® Methotrexate : Treatment for rheumatoid arthritis  

Methotrexate is the standard treatment for rheumatoid arthritis.

ZENEO® Terbutaline

Visuel du produit
Description du produit

ZENEO® Terbutaline : Treatment for severe asthma crisise

Worldwide, there are approximately 235 million people suffering from asthma with 383,000 annual deaths attributed to the disease.

Marketing authorization

US and Europe Marketing Authorisation filings are planned for 2019 (ZENEO® Sumatriptan, ZENEO® Midazolam, ZENEO® Adrenaline, ZENEO® Hydrocortisone and ZENEO® Naloxone) and 2020 (ZENEO® Methotrexate and ZENEO® Terbutaline).